Health Invex raises $26m for clinical trials Invex Therapeutics has received a $5 million investment from Andrew Forrest's Tattarang as part of a share placement, with the proceeds to go towards the company's research into neurological diseases. 22 May 2020
Technology, Innovation & Science New WA ASX listing closes up 169% Invex Therapeutics has become just the third WA-based company to list on the ASX this year, with Minderoo Group its largest shareholder. 05 Jul 2019
